Evaluation of the medical care quality indicators for the pharmacotherapy of patients with ischemic stroke: a hospital-based study

Oksana  Levytska; Bohdan  Hromovyk; Tetiana Ryvak; Kateryna  Kostyana

doi:10.5937/arch of pharm70-26191

Oksana Levytska Danylo Halytsky Lviv National Medical University, Department of Organization and Economics of Pharmacy
Bohdan Hromovyk Danylo Halytsky Lviv National Medical University, Department of Organization and Economics of Pharmacy
Tetiana Ryvak Danylo Halytsky Lviv National Medical University, Department of Clinical Pharmacy, Pharmacotherapy and Medical Standardization
Kateryna Kostyana Danylo Halytsky Lviv National Medical University, Department of Clinical Pharmacy, Pharmacotherapy and Medical Standardization

DOI: https://doi.org/10.5937/arch%20of%20pharm70-26191

Keywords: ischemic stroke, quality of medical care, medications, pharmacotherapy, clinical indicator for quality

Abstract

Ischemic stroke belongs to the leading causes of death and disability in the world and Ukraine. The surviving rates depend on the quality of the provided medical care.

The research aimed to analyze the quality of medical care related to pharmacotherapy of ischemic stroke. The clinical indicators for quality are the quantitative or qualitative indicants that have evidence or consensus of direct influence on it. Six of them relate to acute ischemic stroke pharmacotherapy (namely, thrombolytic, antiplatelet, anticoagulant, and lipid-lowering agents use at different stages of hospital stay) and were investigated in this retrospective analysis of 151 patients’ medical records of one of the specialized hospital departments in Lviv city.

The clinical indicators for quality of medical care showed that pharmacological treatment using antithrombotics (antiplatelets and anticoagulants) at the admission to the hospital corresponded to standards and quality was defined as high with rates of 65.6% and 85.4%. At discharge, the indicator analysis of pharmacotherapy revealed existing problems for antithrombotic (2 indicators) and lipid-lowering (1 indicator) pharmacotherapy with rates of 33.3% and 47.7%.

The outcomes concluded the existence of problems related to pharmacotherapy. The complex of three algorithms was introduced to improve the quality of medical care.

References

Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics – 2019. Update: A Report from the American Heart Association. Circulation. 2019;139:e56-e528. Available from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000659.

Katan M, Luft A. Global Burden of Stroke. Semin Neurol. 2018;38(2):208-11. doi: 10.1055/s-0038-1649503.

Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K et al. American Heart Association Stroke Council. 2018 Guidelines for the Early Management of Patients with Acute Ischemic Stroke: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46-e110. Available from: https://www.ahajournals.org/doi/10.1161/STR.0000000000000158.

Freeman WD, Dawson SB, Raper C, Thiemann K, Josephson SA, Barrett KM. Neurohospitalists reduce length of stay for patients with ischemic stroke. Neurohospitalist. 2011;1(2):67-70. doi:10.1177/1941875210394202.

Basheti IA, Ayasrah SM, Ahmad M. Identifying treatment related problems and associated factors among hospitalized post-stroke patients through medication management review: A multi-center study. Saudi Pharm J. 2019;27(2), 208-19. doi: 10.1016/j.jsps.2018.10.005.

Di Simone E, Giannetta N, Auddino F, Cicotto A, Grilli D, Di Muzio M. Medication errors in the emergency department: Knowledge, attitude, behavior, and training needs of nurses. Indian J Crit Care Med. 2018;22:346-52. doi: 10.4103/ijccm.IJCCM_63_18.

Jellinek-Cohen SP, Li M, Husk G. Enoxaparin dosing errors in the emergency department. World J Emerg Med. 2018;9(3):195-202. doi: 10.5847/wjem.j.1920-8642.2018.03.006.

Michaels AD, Spinler SA, Leeper BE, Ohman M, Alexander K P, Newby KL et al. Medication errors in acute cardiovascular and stroke patients: a scientific statement from the American Heart Association. Circulation, 2010;121:1664-82. Available from: https://www.ahajournals.org/doi/10.1161/CIR.0b013e3181d4b43e.

Ormseth CH, Sheth KN, Saver JL, Fonarow GC, Schwamm LH. The American Heart Association’s Get with the Guidelines (GWTG)-Stroke development and impact on stroke care. Stroke and Vascular Neurology, 2017; 2:e000092. doi: 10.1136/svn-2017-000092. Available from: https://svn.bmj.com/content/2/2/94.

Turner GM, Calvert M, Feltham MG, Ryan R, Finnikin S, Marshall T. Clinical and Demographic Characteristics Associated With Suboptimal Primary Stroke and Transient Ischemic Attack Prevention: Retrospective Analysis. Stroke. 2018;49(3):682-7. Available from: https://www.ahajournals.org/doi/10.1161/STROKEAHA.117.020080.

Ung D, Kim J, Thrift AG, Cadilhac DA, Andrew NE, Sundararajan V et al. Promising Use of Big Data to Increase the Efficiency and Comprehensiveness of Stroke Outcomes Research. Stroke. 2019;50:1302-9. Available from: https://www.ahajournals.org/doi/10.1161/STROKEAHA.118.020372.

The Ljubljana Charter on Reforming Health Care. BMJ. 1996;312(7047):1664-5. Available from: http://www.euro.who.int/en/publications/policy-documents/the-ljubljana-charter-on-reforming-health-care,-1996.

Vuori HV. Quality assurance of health services: concepts and methodology: Copenhagen: Regional Office for Europe. World Health Organization; Albany, N.Y.: WHO Publications Centre: 1982. 127 p. Available from: https://trove.nla.gov.au/version/26291550.

Emmett E, Stevens E, Wang Y, McKevitt C, Wolfe C DA. The Burden of Stroke in Europe Report. King's College London for the Stroke Alliance for Europe (SAFE): 2017. Available from: https://www.stroke.org.uk/sites/default/files/the_burden_of_stroke_in_europe_-_challenges_for_policy_makers.pdf.

Ischemic stroke (emergency, primary, secondary (specialized) medical care, medical rehabilitation). Unified clinical protocol of medical care. [Internet]. Order of the Ministry of Health of Ukraine; No.602, 2012, Aug 3 [cited 2018 Jul 5]. Available from: https://zakon.rada.gov.ua/rada/show/v0602282-12#n2.

Rehabilitation, prevention and treatment complications and discharge planning for ischemic stroke. Adapted clinical guideline based on evidence. [Internet]. Order of the Ministry of Health of Ukraine; No.602, 2012, Aug 3 [cited 2018 Jul 10]. Available from: http://mtd.dec.gov.ua/images/dodatki/2012_602/2012_602dod5AKN.pdf.

Recommendations for the management of patients with ischemic stroke and transient ischemic attack. Adapted clinical guideline based on evidence. [Internet]. Order of the Ministry of Health of Ukraine; No.602, 2012, Aug 3 [cited 2018 Jul 8]. Available from: https://zakon.rada.gov.ua/rada/show/va602282-12#n4.

Modern principles of diagnosis and treatment of patients with acute ischemic stroke and transient ischemic attack. Adapted clinical guideline based on evidence. [Internet]. Order of the Ministry of Health of Ukraine; No.602, 2012, Aug 3 [cited 2018 Jul 15]. Available from: https://dec.gov.ua/wp-content/uploads/2019/11/2012_602dod1akn.pdf.

Systemic thrombolysis in ischemic stroke (emergency, secondary (specialized) medical care. Unified clinical protocol of medical care. [Internet]. Order of the Ministry of Health of Ukraine; No.602, 2012, Aug 3 [cited 2018 Jul 24]. Available at: https://zakon.rada.gov.ua/rada/show/vb602282-12#n3.

Donabedian A. The Quality of care: how can it be assessed? JAMA, 1988;12:1743-8. doi: 10.1001/jama.260.12.1743.

Mainz J. Defining and classifying clinical indicators for quality improvement: Int J Qual Health Care. 2003;15(6):523-530. Available from: https://doi.org/10.1093/intqhc/mzg081.

Measuring and improving quality of care: A report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke, 2000;31(4):1002-12. doi: 10.1161/01.cir.101.12.1483.

Reeves MJ, Parker C, Fonarow GC, Smith EE, Schwamm LH. Development of stroke performance measures: definitions, methods, and current measures. Stroke. 2010;41(7):1573-80. Available from: https://www.ahajournals.org/doi/10.1161/STROKEAHA.109.577171.

Peacock J, Peacock P. Oxford Handbook of Medical Statistics. Oxford University Press: 2011. 544 p.

Cooray C, Mazya M, Mikulik R, Jurak L, Brozman M, Ringleb P et al. Safety and Outcome of Intravenous Thrombolysis in Stroke Patients on Prophylactic Doses of Low Molecular Weight Heparins at Stroke Onset. Stroke, 2019;50:1149-55. doi: 10.1161/STROKEAHA.118.024575.

Gorodnycha O, Zimenkovsky A, Kostyana K. Drug-related problems associated with use of statins in Ukraine: a hospital-based study. Pharmacia. 2016;63(4):29-34.

Wittich CM, Burkle CM, Lanier WL. Medication errors: an overview for clinicians. Mayo Clin Proc. 2014;89(8):1116-25. Available from: https://doi.org/10.1016/j.mayocp.2014.05.007.

Lindsay PM, Kapral MK, Holloway R, Gladstone DJ, Tu JV, Laupacis A, Grimshaw JM. Canadian Stroke Quality of Care Study: Identification of performance indicators for acute stroke care. CMAJ. 2005;172(3):363-5. doi: 10.1503/cmaj.045310.

Levytska OR, Hromovyk BP, Unhurian LM, Kostyana KV. Clinical-epidemiological and pharmacoepidemiological investigation of acute cerebrovascular accidents. Journal of Applied Pharmaceutical Science. 2017;7(07):168-75. doi: 10.7324/JAPS.2017.70725.